{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "New York",
      "address_1": "599 W 190th St Ste 1",
      "reason_for_recall": "Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss",
      "address_2": "",
      "product_quantity": "UNKNOWN",
      "code_info": "Lot #: 20213, Exp 12/22/2016.",
      "center_classification_date": "20150324",
      "distribution_pattern": "Nationwide",
      "state": "NY",
      "product_description": "B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.",
      "report_date": "20150401",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Bethel Nutritional Consulting, Inc",
      "recall_number": "D-0424-2015",
      "initial_firm_notification": "Press Release",
      "product_type": "Drugs",
      "event_id": "70096",
      "termination_date": "20180604",
      "more_code_info": "",
      "recall_initiation_date": "20141219",
      "postal_code": "10040-3577",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}